A new clinical trial highlights the promising blood sugar and lipid benefits of a chromium-flavonoid supplement
A recent Italian clinical trial published in Frontiers in Nutrition suggests that a daily blend of citrus and grape compounds combined with chromium could normalize blood sugar and improve lipid balance in adults with prediabetes, achieving results faster than dietary changes alone. The findings offer growing evidence that certain nutraceuticals may complement lifestyle interventions in preventing type 2 diabetes.
Rising Prediabetes Rates Demand New Approaches
Prediabetes, or impaired fasting glucose (IFG), affects millions worldwide and significantly increases cardiovascular risk. Although lifestyle changes remain the cornerstone of prevention, adherence challenges often limit success. Researchers from Italy sought to evaluate whether a targeted chromium-flavonoid blend could accelerate improvements in glucose metabolism and lipid control among individuals with IFG following an isocaloric DASH diet.
Explore All Endocrinology CME/CE Conferences and Online Courses
Clinical Trial Reveals Significant Glucose and Lipid Improvements by Citrus and Grape Compounds
The randomized, double-blind, placebo-controlled study involved 62 adults (ages 18–75) with IFG. Participants received either a placebo or a supplement containing 250 µg of chromium and 560 mg of flavonoids derived from Citrus limon, Vitis vinifera, and Citrus sinensis over six months.
Results were striking; fasting blood glucose in the supplement group dropped from 114 to 94 mg/dL, reaching normal levels within three months, compared with modest improvements in the placebo group. Additionally, the supplement significantly lowered LDL cholesterol, increased HDL, and reduced triglycerides, demonstrating potential cardiovascular benefits. Notably, all safety markers, including liver and kidney parameters, remained stable, indicating good tolerability.
A Safe Nutritional Strategy for Metabolic Health
Lead investigators noted that the synergistic action of hesperidin, flavonoids, and chromium may enhance insulin sensitivity and oxidative balance. These effects could provide a complementary, non-pharmacological tool for metabolic management in people at risk of developing type 2 diabetes.
While the findings are promising, researchers recommend larger, multi-center trials to confirm the supplement’s long-term benefits and generalizability across diverse populations.
What This Means for Healthcare Professionals
For clinicians and nutrition-focused HCPs, this study underscores the potential of bioactive plant compounds in preventive care strategies for prediabetes and dyslipidemia. Integrating evidence-based nutraceuticals with dietary and behavioral counseling could strengthen patient adherence and improve early metabolic outcomes.
Citation: Frontiers in Nutrition – “Impact of a food supplement containing Citrus limon L. Osbeck and Vitis vinifera L. extracts, hesperidin and chromium in combination with an isocaloric diet on glucose and lipid metabolism in subjects with impaired fasting blood glucose.”
Source:
more recommended stories
Phage Therapy Study Reveals RNA-Based Infection ControlKey Takeaways (Quick Summary) Researchers uncovered.
Pelvic Floor Disorders: Treatable Yet Often IgnoredKey Takeaways (Quick Summary) Pelvic floor.
Urine-Based microRNA Aging Clock Predicts Biological AgeKey Takeaways (Quick Summary) Researchers developed.
Circadian Control of Neutrophils in Myocardial InfarctionKey Takeaways for HCPs Neutrophil activity.
E-Cigarette Use and Heart Attack Risk in Former SmokersKey Takeaways for Clinicians and Nurses.
Ultramarathon Physiology: What HCPs Should Know?Ultramarathon Metabolism: What Happens to the.
High-Intensity Training and Oxidative Stress InsightsNew Evidence Linking High-Intensity Training and.
Sterilized Fermented Beverage for Obesity: New EvidenceEarly Insights Into a Sterilized Fermented.
36-Week Pre-eclampsia Screening May Reduce Term RiskA New Preventive Strategy for Term.
Cardiovascular Risk and Sudden Cardiac Death in DiabetesRising Sudden Cardiac Death (SCD) Risk.

Leave a Comment